Merck Presents New Findings Showing Anti-Tumor Activity of KEYTRUDA in Patients with Advanced NPC
September 26, 2015 at 07:33 AM EDT
Merck (NYSE: MRK) today announced the first-time presentation of findings investigating the use of KEYTRUDA® ...
